Codex DNA, Inc. is a new focused synthetic biology company developing lab instruments, reagents, and associated products while providing various other services. Codex DNA's products include the ...

Codex DNA, Inc. Proof-of-concept studies go beyond typical DNA data storage projects to ensure high-fidelity data recovery within an automated synthetic biology workflow ...

Codex DNA is well capitalized with cash and short-term investments of $61.9 million as of June 30, 2022. Revenue was $5.7 million for the second quarter 2022, ...

SAN DIEGO, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced the release of a new full-length synthetic ...

Codex DNA, fresh off raising $122 million in an initial public stock offering in June, has inked a deal to buy privately held Eton Bioscience — combining two of San Diego’s synthetic biology ...

Codex DNA (DNAY) is a $267m market cap biotech that IPOd in June last year, raising $123m at $16 per share. The company was spun out of Synthetic Genomics (since renamed Viridos) in 2019, having ...

What happenedWednesday will go down in history for Codex DNA (NASDAQ: DNAY). The genetics-focused biotech saw its share price rocket 39% higher, thanks to a potentially very lucrative deal with a ...

San Diego, April 06, 2020 (GLOBE NEWSWIRE) -- SGI-DNA, Inc., creators of the world’s first fully automated system for high-throughput writing of DNA, the BioXp™ 3200 system, today announced ...

--Codex DNA, Inc., a pioneer in automated benchtop synthetic biology systems, announced today that it has agreed to acquire Eton Bioscience, a privately held provider of synthetic biology products ...

Todd R. Nelson, Ph.D., has served as the President, Chief Executive Officer and a member of the board of directors of Codex DNA (NASDAQ:DNAY) since July 2018. Prior to joining the company, Dr ...

Pfizer’s successful development and commercialization of licensed products could result in milestone payments in excess of $100 million SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- ...

Good day, and thank you for standing by. Welcome to the second-quarter 2021 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation ...